Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

Arrowhead Pharmaceuticals Corp (ARWR) Appoints William Waddill to Board of Directors

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors elected veteran biotechnology executive William Waddill as an independent director of the company, with a term beginning effective January 1, 2018. It is anticipated that Mr. Waddill will serve on the Audit, ...

Mentions: Independent Director Nasdaq William Waddill